Navigation Links
Bacteria use host's immune response to their competitive advantage

Millions of bacteria live within the recesses of our noses and upper respiratory tracts, waiting for a chance to infiltrate and infect. But long before these bacteria break through our immune defenses, they must first compete against other bacterial species to colonize the mucus-lined surfaces of our noses.

Competition between two common nose bacteria involves some interesting trickery, according to a new study in PLoS Pathogens. "We're looking at how bacteria use their host, and we've found that the presence of one species leads to the elimination of another," says Jeffrey Weiser, coauthor of the study and professor of pediatrics and microbiology at the University of Pennsylvania, School of Medicine.

In a mouse model, Haemophilus influenzae--a common bacterium that infects children--stimulates the immune system to send out specialized white blood cells that attack its competitor, Streptococcus pneumoniae--a leading cause of pneumonia. "It is striking that the host's response can so completely eliminate the competitor," says Weiser.

The findings also demonstrate how antibiotics and vaccines that target one microbe might inadvertently alter the competitive interactions among other species present.

###

Citation: Lysenko ES, Ratner AJ, Nelson AL, Weiser JN (2005) The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces. PLoS Pathogens 1(1): e1.


'"/>

Source:Public Library of Science


Page: 1

Related biology news :

1. Bacteria collection sheds light on urinary tract infections
2. Solution to Pollution: New Bacteria Eats Toxic Waste
3. The Bacterias guide to survival
4. UF Researchers Map Bacterial Proteins That Cause Tooth Loss
5. Bacterial genome sheds light on synthesizing cancer-fighting compounds
6. Where Bacteria Get Their Genes
7. Bacteria feed on smelly breath (and feet)
8. New insight into autoimmune disease: Bacterial infections promote recognition of self-glycolipids
9. Say what? Bacterial conversation stoppers
10. Bacteria are key to green plastics, drugs
11. Researchers Discover Ancient Origins Of Tuberculosis-causing Bacteria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
(Date:3/17/2016)... , March 17, 2016 ABI ... intelligence, forecasts the global biometrics market will reach ... impressive 118% increase from 2015. Consumer electronics, particularly ... embedded fingerprint sensors anticipated to reach two billion ... Dimitrios Pavlakis , Research Analyst at ...
(Date:3/11/2016)... , March 11, 2016 http://www.apimages.com ) ... Cross reference: Picture is available at AP Images ( http://www.apimages.com ) ... DERMALOG will be used to produce the new refugee identity cards. ... biometric innovations, at CeBIT in Hanover next ... from DERMALOG will be used to produce the new refugee identity ...
Breaking Biology News(10 mins):
(Date:5/5/2016)... ... May 05, 2016 , ... American Process, Inc. (API) ... U.S. Patent Nos. 9,322,133 and 9,322,134, to API and its affiliated companies for ... as hydrophobic nanocellulose compositions. In addition to these patents and U.S. Patent ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... identification of its first three targets, it has identified a fourth in a ... implicated in the development and progression of Alzheimer’s disease (AD). , ...
(Date:5/4/2016)... ... May 04, 2016 , ... Looking for a ... Diego’s premiere hands-on cooking experience. Offering everything from gourmet cooking classes to weekend ... won’t forget. , Guests that visit LaJollaCooks4u share an experience unlike any other. ...
(Date:5/4/2016)... WHIPPANY, N.J. , May 4, 2016 /PRNewswire/ ... evaluating its oncology compound Stivarga ® (regorafenib) ... hepatocellular carcinoma (HCC) has met its primary endpoint ... The study, called RESORCE, evaluated the efficacy and ... disease has progressed after treatment with sorafenib. The ...
Breaking Biology Technology: